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We thank Dr Izgi and colleagues for their interest in our article. 1 The subcellular localization of the neutral sphingomyelinase involved in cell signaling remains unclear. The neutral sphingomyelinases are generally considered as membraneassociated enzymes, 2 and, recently, the neutral sphingomyelinase-2 involved in cell signaling has been shown to translocate at the plasma membrane. 3 Moreover, as a large part of the substrate (sphingomyelin) is located in rafts/ caveolae, and as membrane type 1 matrix metalloproteinase (MT1-MMP) and MMP-2 have also been localized in rafts, it is not excluded that the interaction between these metalloproteases and the neutral sphingomyelinase may occur in rafts/ caveolae. However, this attractive hypothesis remains to be firmly demonstrated.
Our data show, for the first time, that both MT1-MMP and MMP-2 are required for the oxidized LDL (oxLDL)-induced activation of the neutral sphingomyelinase and subsequent sphingomyelin/ceramide pathway, as assessed by the use of pharmacological inhibitors, anti-MMP-2 and anti-MT1-MMP blocking antibodies, small-interference RNA directed to MMP-2, fibroblasts from MMP-2 Ϫ/Ϫ mice, and recombinant (r) MT1-MMP and rMMP-2. But our data do not exclude the hypothesis of Gingras et al 4 that endogenous MT1-MMP could act as coactivator by its cytoplasmic domain. The molecular mechanisms by which MT1-MMP and MMP-2 activate the neutral sphingomyelinase remain unanswered because, to date, several questions concerning the nature and precise localization of this sphingomyelinase are unknown. For instance, we do not know whether (1) MT1-MMP and MMP-2 act directly on the neutral sphingomyelinase or on regulatory proteins (activator or inhibitor or adaptor?); (2) MT1-MMP and MMP-2 act only by their proteolytic activity or require the coactivating cytoplasmic domain of MT1-MMP, according to Gringas et al 4 ; (3) MMP-2 activation requires the formation of a complex involving TIMP-2, activator(s), MT1-MMPs, and integrins as a docking system 5 ; or (4) sphingomyelinase activation is regulated by proteins of the extracellular matrix (collagen IV, elastin, and thrombospondin) that are known to regulate MT1-MMP and MMP-2. 5 Finally, our report is focused on the novel role of MT1-MMP and MMP-2 as activators of the signaling sphingomyelinase activated by oxLDL, but the fine molecular mechanisms linking these metalloproteases to the (yet-unidentified) neutral sphingomyelinase remain to be elucidated.
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